Innovations  by unknown
One-step genome 
analysis 
Synteni, Inc. 
Ignore all claims from genome- 
project proponents that grne 
discovery is dead. lJnti1 the function 
of each and every gent is 
determined, it will be vital to 
rediscover genes in different 
CO~CXCS so they can be placed in the 
right part of the biological puzzle. 
Synteni, in Palo Alto, California, is 
promoting one of the more recently 
devised methods of gene discovery 
and rediscovery, which uses arrays of 
complementary DNA (cDNA) clones 
on chips. The chips can assess the 
relative expression levels of 
thousands of genes simultaneously, 
information that can be used in drug- 
discovery projects, diagnosis, 
toxicology and basic research. Genes 
whose expression increases or 
decreases under a particular 
condition can be pulled our and 
studied as potential regulators or 
effecters of that condition. 
The technology 
In 1992 Patrick Brown of Stanford 
University was contemplating a 
forbidding task-a complex 
hybridization involving many probes 
and many targets that would help 
him in a linkage-mapping 
experiment. It occurred to Brown 
that hybridization technology could 
be pushed a great deal further with 
some iqtelligent engineering, and CO 
rake on this project he enlisted Dari 
Shalon, Mark Schena and Ron Davis. 
Shalon, now President and CEO of 
Synteni, was a doctoral student in 
Bmwn’s laboratory at the time. 
The results of their labors were 
published in &&se in 1995. ‘The 
Innovations is a new monthly column that 
surveys the science done at biotechnology 
companies. 
principles arc very simple,’ says 
Brown, ‘and it’s very robust’. A 
robotic device dips tiny capillaries 
into the wells of a standard microwcll 
plate containing solutions of 
individual cDNAs. Loading of the 
solution into the capillaries is driven 
by surface tension, and the solutions 
are ‘printed’ onto a glass slide with a 
gentle tap. The robot offsets the next 
set of samples slightly so clones can 
be deposited with as little as 100 p.m 
between them. The DNA is linked 
to the slide by various chemistries, 
heat-denatured, and probed with 
mixtures of other cDNAs that have 
fluorescent markers attached. If the 
fluorcsccnt probes stick, the 
hybridization is detected by a laser 
confucal scanner (see Fig. 1). 
Why is this useful? 
The choice of glass chips and 
iluorescent detection is not random. 
Fluorescent signals do not disperse 
and so can be used at high density. 
More importantly, several fluorescent 
detectors can be used at once. This 
allows the expression levels of large 
numbers of genes to be compared 
simultaneously. In the original Science 
papa, for cxamplc, the authors 
probed a panel of plant cDNAs with 
total cDNA obtained from mot and 
leaf mRNA. A clone that hybridized 
with the leaf probe more strongly 
than with the root probe would 
obviously be of interest to a 
researcher studying leaf devclopmcnt 
or physiology. Since then, the 
Stanford and Synteni groups have 
analyzed samples collected both 
before and after heat shock, addition 
of phorbol esters (acrivators of 
growth-promoting signal-transduction 
pathways) and addition of a chromo- 
some 6 fragment that suppresses the 
tumorigenic properties of a human 
melanoma cell line. 
Synteni now has a long list of 
clients, including a number of the 
largest pharmaceutical companies. 
The company does not disclose the 
nature of these projects, but Shalon 
says they fall into several classes. 
The most exciting type of project 
Fiaure I 
A sample experiment using a Syntani chip, in 
which 1056 clones randomly selected from a 
peripheral lymphocyfe library were printed 
onto a 1 cm2 chip. Two probe ssfs (Jurkat 
cell total cDNA (green) and bone marrow 
total cDNA (red)) were then hybridized lo the 
array. The intensity of the signal gives an 
indication of the expression lewl. The 
greener the spot, the more that gene is 
expressed in lurkat cells; the redder the spot, 
the more that gene is expressed in bone 
marrow. Yellow spats indicate equal 
expression of the gene in the two tissues. 
The colors are for visualization purposes only; 
expression levels are normally quantified in 
numerical term. 
involves the direct identification ofa 
drug target. The target gene is 
identified on rhe basis ofits 
increased expression in a cell where a 
target pathway (such as an 
inflammatory response) is known to ‘; 
he activated. In theory, Synreni 
should be able to waluate entire 
pathways, identifying, for example, 
all genes whose expression is 
regulated by a particular transcription 
factor. A second type of project uses 
smaller chips displaying a few well 
characterized clones to provide an 
initial toxicity screen for drug 
candidates. Using this screen, 
Synteni can detect whether.cells 
treated with a compound increase the 
expression of damage-induced genes; 
if so, animal testing is less likely to 
he warranted. Finally, the chips can 
be used for the diagnosis of certain 
disease states chat have characteristic 
patterns of gene expression. 
The competition - cDNAanalysis 
In an area with so many applications 
it is not surprising that Synteni is nor 
Synteni and cDNA arrays vs. Affymetrlx and oligonucleotide arrays - claim and counterclaim. 
Synteni claims that their chips... Affymetrix counters that... - -___~- 
Can be used to discover unknown genes. This is soon to be irrelevant with the pace of genome projects. 
Can use arrays with less features (1 spot = 1 gene). True, although the greater density of oligonucleotides partially offsets this. Also. no 
gene is repeated in Affymetrix arrays. whereas cDNAs are often repeated in libraries. 
Show less confradiction in hybridization results. as longer Affymetrix’s mismatch controls detect false positives. Any conflicting information is 
probes give less false positives. processed by a fully automated algorithm. 
Can differentiate behveen genes that are up to 70% Affymetrix chips have better resolution, and can differentiate belween closely 
homologous because o‘ long probes. related hamologs and splice variants. 
Have good quality control. Much of the variability that If the oligonucleotide arrays fail it is usually at the lewl of the whole chip, and this is 
occurs in chip vansfruction does not affect the results. as easily detected. For the cDNA arrays each spot is a separate quality control problem. 
what matters is the ratio of results not the absolute values. 
Are built with simpler technology. Building Aflymetrix chips only requires seauence information. not cDNA libraries. 
alone. Hyseq, of Sunnyvale, 
California, uses two techniques 
originally developed for DNA 
sequencing ID provide much the 
same types of information that 
Synteni does. Radoje Drmanac, 
Senior Vice-President for Research, 
explains that, in the first technique, 
Hyseq arrays random clones from 
cDNA libraries on membranes, then 
hybridizes a series of oligonucleo- 
tides to the clones (usually 300 
distinct hybridizations, each with a 
diffcrcnt 7.me,). Clones that show 
identical hybridization patterns are 
deduced to be identical, and their 
frequency in an array gives a measure 
of their expression level. ‘It’s a more 
cumbersome approach,” says Shalon, 
pointing out that each sample must 
be hybridized many times and that 
the numbcr of cDNA clones that 
must be arrayed is very large. 
Drmanac counters with the 
assertions that Hyseq has the ability 
to array enough clones, and that any 
approach using cDNAs should 
attempt such coverage in any case. 
“This holistic approach is critical,’ he 
says. Synteni uses similar arrays of 
raudom cDNAs in home cases, 
primarily for gene discovery. 
Testing known genes 
Some of the applications mentioned 
above do not require gene discovery, 
using instead arrays of known genes. 
As gtmome projects advance, arrays of 
known genes or expressed sequence 
tags (ESTs) will expand, and probably 
replace the redundant random cDNA 
arrays even in target discovcry 
projects. The Synteni technique can 
be directly adapted to this approach, 
and -50 % of their chips already 
contain known cDNAs. Hyseq have 
developed a second technique to 
monitor known genes, in which they 
spot arrays of oligonucleotides, 
hybridize cDNAs, and then probe 
with a second set of oligonuclcotides. 
The double-hit hybridization process 
means that they only need two probe 
sites per gene. Their largest array can 
monitor the expression of 100 000 
genes in 384 cm2. 
The competition - oligonucleotides 
The closest competition in 
oligonucleotide-chip technology is, 
however, Affymetrix Inc. of Palo 
Alto, California. Affymetrix, founded 
in 1992 as a daughter company of 
Affymax N.V.*, forms its arrays of 
oligonucleotides by &irect synthesis 
on the chip instead of ‘printing’ 
spots of pre-made cDNAs. 
Affymetrix has been using its chips 
for DNA sequencing, but have 
recently entered the area of 
expression-level analysis. 
Affymetrix’s technology uses a 
photolithographic mask to allow 
photolabile groups to be 
deprotected selectively according to 
their precise position on the chip, 
and builds up oligonucleotides by 
repeated cycles of deprotection and 
coupling. Up to 400 000 different 
oligonucledtides are routinely 
synthesized on a -1.6.cm2 chip, A 
gene can be rcpresentcd by 20 
different oligonucl&idcs plus 20 
mismatch oligonucleotides as 
controls, so the expression levels 
of up to 10 000 genes can be 
measured on a single chip. This gene 
density doesn’t yet reach that of a 
Synteni chip, although these 
densities are constantly evolving. 
The two companies have a well- 
developed debate about which 
approach works best (Table 1). On 
one of the most important issues, 
specificity, both sides claim 
superiority for different reasons. 
Does more complicated 
technology always win? Shalon 
doesn’t think so. ‘So far we 
haven’t lost a single customer to 
Affymetrix,’ he says. For now it 
seems that, despite all the claims of 
great speed by both companies, 
there is more than enough work to 
go around. 
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